Cyclomarins are highly potent antimycobacterial and antiplasmodial cyclopeptides isolated from a marine bacterium (Streptomyces sp.). Previous studies have identified the target proteins and elucidated a novel mode of action, however there are currently only a few studies examining the structure-activity relationship (SAR) for both pathogens. Herein, we report the synthesis and biological evaluation of 17 novel desoxycyclomarin-inspired analogues. Optimization via side chain modifications of the non-canonical amino acids led to potent lead structures for each pathogen.
Keywords: Mycobacterium tuberculosis; Plasmodium falciparum; malaria; multiple-drug-resistance; tuberculosis.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.